Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis
- 2 February 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 116, 109797
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Helios Induces Epigenetic Silencing of Il2 Gene Expression in Regulatory T CellsThe Journal of Immunology, 2013
- Self-tolerance in multiple sclerosisActa Neurologica Belgica, 2012
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2010
- Multiple Sclerosis and Regulatory T CellsJournal of Clinical Immunology, 2008
- Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patientsClinical and Experimental Immunology, 2007
- Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expressionJournal of Neuroscience Research, 2006
- Pharmacokinetic Behavior of RituximabTherapeutic Drug Monitoring, 2005
- Decreased FOXP3 levels in multiple sclerosis patientsJournal of Neuroscience Research, 2005
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisJournal of Experimental Medicine, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001